1980
DOI: 10.1021/bi00551a031
|View full text |Cite
|
Sign up to set email alerts
|

Photoaffinity labeling of insulin receptor with an insulin analog selectively modified at the amino terminal of the B chain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
17
0

Year Published

1980
1980
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(19 citation statements)
references
References 43 publications
2
17
0
Order By: Relevance
“…The most intensely labeled polypeptide that significantly penetrated the gel had a Mr of 130,000 (Fig. 1, lane 2), a value similar to that reported for the insulin-binding component of the receptor in other cells (4,6,11,13,14). The Mr 130,000 polypeptide migrated with the insulin-binding subunit identified when affinity crosslinking with "2I-insulin was restricted to proteins accessible on the surface of intact 3T3-L1 adipocytes (Fig.…”
Section: Resultssupporting
confidence: 73%
See 1 more Smart Citation
“…The most intensely labeled polypeptide that significantly penetrated the gel had a Mr of 130,000 (Fig. 1, lane 2), a value similar to that reported for the insulin-binding component of the receptor in other cells (4,6,11,13,14). The Mr 130,000 polypeptide migrated with the insulin-binding subunit identified when affinity crosslinking with "2I-insulin was restricted to proteins accessible on the surface of intact 3T3-L1 adipocytes (Fig.…”
Section: Resultssupporting
confidence: 73%
“…1). This size contrasts markedly to the Mr of 130,000 established for the insulin-binding subunit on the surface of a number of target tissues and cells (4,6,11,13,14). Because the Mr 200,000 polypeptide (i) has a short halflife, (ii) is the only insulin-binding protein resistant to functional inactivation by externally added proteolytic enzymes, and (iii) contains a hormone-binding site inaccessible at the cell surface ( Fig.…”
Section: Resultsmentioning
confidence: 91%
“…The insulin receptor has been well established to exist minimally as a heterotetrameric disulphide-linked complex consisting of two Mr-130000 (a) and two Mr-95000 (,O) subunits (Hedo et al, 1981;Massague et al, 1981;Van Obberghen et al, 1981;Fujita-Yamaguchi, 1984;Boyle et al, 1985). It is thought that the a subunit encompasses the high-affinity insulin-binding site (Yip et al, 1978(Yip et al, , 1980Jacobs et al, 1979;Pilch & Czech, 1980;Yeung et al, 1980), whereas the , subunit contains a single hydrophobic transmembrane domain (Ebina et al, 1985;Ullrich et al, 1985), an intracellular ATPbinding site (Roth & Cassell, 1983;Van Obberghen et al, 1983), as well as tyrosine-autophosphorylation receptor sites (Avruch et al, 1982;Kasuga et al, 1982aKasuga et al, ,b,c, 1983aPetruzzelli et al, 1982Petruzzelli et al, , 1984Tamura et al, 1983;Zick et al, 1983).…”
Section: Introductionmentioning
confidence: 99%
“…Specific functional properties are associated with the individual subunits: the a subunit contains the hormone binding site (Massague et al, 1980;Siegel et al, 1981;Jacobs et al, 1979;Wisher et al, 1980;Yeung et al, 1980;Kasuga et al, 198 1 b) while serine and tyrosine residues in the /3 subunit serve as phosphate acceptors in insulin-stimulated phosphorylation reactions (Kasuga et al, 1982a,b;Petruzzelli et al, 1982;Avruch et al, 1982). Recent reports suggest that the j3 subunit exhibits an intrinsic tyrosine protein kinase activity and catalyzes the autophosphorylation of the receptor (Roth & Cassell, 1983;Van Obberghen et al, 1983;Shia et al 1983;Roth et al 1983).…”
mentioning
confidence: 99%